These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21513065)

  • 1. [Cholinesterase blockers in anesthesiology: a replenishment of former arsenal].
    Buniatian AA; Stamov VI; Mizikov VM; Peĭkarova AV
    Anesteziol Reanimatol; 2011; (1):4-8. PubMed ID: 21513065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new method in the treatment of migraine using anticholinesterase drugs (clinical observations)].
    Ikonomoff SI
    Schweiz Arch Neurol Neurochir Psychiatr; 1968; 102(2):299-312. PubMed ID: 5734592
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease].
    Blesa R; García Ribas G; Galdós L; Olascoaga J; Amer G; Marey López J; Barquero M; Marsall C; Ezpeleta D
    Neurologia; 2006; 21(6):289-96. PubMed ID: 16799903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neostigmine for the treatment of acute colonic pseudo-obstruction.
    Ponec RJ; Saunders MD; Kimmey MB
    N Engl J Med; 1999 Jul; 341(3):137-41. PubMed ID: 10403850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
    Griffith HR; Martin R; Andrews S; LeBron Paige A; Ware J; Faught E; Welty T
    Epilepsy Behav; 2008 Aug; 13(2):376-80. PubMed ID: 18556248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW; Yik PY; Mok W; Chung CP
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
    Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine as an adjunctive treatment in major depression.
    Elgamal S; MacQueen G
    J Clin Psychopharmacol; 2008 Jun; 28(3):357-9. PubMed ID: 18480702
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
    Isik AT; Bozoglu E; Naharci MI; Kilic S
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostigmine-induced prolonged neuromuscular blockade in a patient with atypical pseudocholinesterase.
    Ramirez JG; Sprung J; Keegan MT; Hall BA; Bourke DL
    J Clin Anesth; 2005 May; 17(3):221-4. PubMed ID: 15896593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complete atrioventricular block during galantamine therapy].
    Leentjens AF; Kragten JA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):563-6. PubMed ID: 16566422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of neuromuscular blocking agents: current practice.
    Nagelhout JJ
    AANA J; 2013 Dec; Suppl():8-11. PubMed ID: 24592527
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W; Reiner T; Khuenl-Brady KS
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.
    Senanarong V; Poungvarin N; Phanthumchinda K; Thavichachart N; Chankrachang S; Praditsuwan R; Nidhinandana S
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S12-8. PubMed ID: 19562980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of galantamine in patients with mild Alzheimer's disease.
    Orgogozo JM; Small GW; Hammond G; Van Baelen B; Schwalen S
    Curr Med Res Opin; 2004 Nov; 20(11):1815-20. PubMed ID: 15537482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged cholinergic effects after the reversal of neuromuscular blockade with neostigmine.
    Carron M; Toniolo A; Ori C
    J Clin Anesth; 2016 Feb; 28():85. PubMed ID: 26239721
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
    Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
    Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.